Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentBeginning Cash BalanceCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Journey Medical (DERM) Asset Writedowns and Impairment: 2020-2024

Historic Asset Writedowns and Impairment for Journey Medical (DERM) over the last 5 years, with Dec 2024 value amounting to $516,000.

  • Journey Medical's Asset Writedowns and Impairment fell 88.67% to $76,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$477,000, marking a year-over-year decrease of 112.03%. This contributed to the annual value of $516,000 for FY2024, which is 83.58% down from last year.
  • Journey Medical's Asset Writedowns and Impairment amounted to $516,000 in FY2024, which was down 83.58% from $3.1 million recorded in FY2023.
  • Journey Medical's Asset Writedowns and Impairment's 5-year high stood at $3.1 million during FY2023, with a 5-year trough of $48,000 in FY2021.
  • For the 3-year period, Journey Medical's Asset Writedowns and Impairment averaged around $1.3 million, with its median value being $516,000 (2024).
  • In the last 5 years, Journey Medical's Asset Writedowns and Impairment soared by 1,006.69% in 2023 and then plummeted by 83.58% in 2024.
  • Journey Medical's Asset Writedowns and Impairment (MRY) stood at $49,000 in 2020, then fell by 2.04% to $48,000 in 2021, then soared by 491.67% to $284,000 in 2022, then surged by 1,006.69% to $3.1 million in 2023, then plummeted by 83.58% to $516,000 in 2024.
  • Its last three reported values are $516,000 in FY2024, $3.1 million for FY2023, and $284,000 during FY2022.